# Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma

> **NCT02859012** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 60 (actual)

## Conditions studied

- Recurrent ACC, metastaticACC, Unreaectable ACC

## Interventions

- **DRUG:** Axitinib
- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT02859012
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-12
- **Final completion:** 2020-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859012, "Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02859012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*